Neoplasia: Benign vs Malignant Tumors & Hallmarks of Cancer

Added:

The Tissue Organization Field Theory (TOFT)

While mainstream oncology relies on the Somatic Mutation Theory (SMT)—which views cancer as a cell-based genetic disease driven by DNA mutations and defines the classic 'Hallmarks of Cancer'—the Tissue Organization Field Theory (TOFT) offers a major alternative paradigm. TOFT posits that carcinogenesis is a tissue-level disease rather than a cellular one. According to this theory, cancer arises from a disruption in the bidirectional communication between cells and their extracellular matrix (the tissue microenvironment), akin to abnormal organogenesis. Instead of genetic mutations driving uncontrolled proliferation, TOFT argues that proliferation is the default state of all cells, and neoplasia occurs when tissue-level constraints and physical architecture break down. This perspective challenges the reductionist, gene-centric view of tumor development and shifts the therapeutic focus from targeting specific genetic mutations to restoring the health and signaling of the surrounding tissue microenvironment.

The eukaryotic cell cycle and its regulation, including major checkpoints and the role of cyclins and cyclin-dependent kinases (CDKs).
Basic genetics, specifically DNA replication, mutation types, and the distinction between proto-oncogenes and tumor suppressor genes.
Normal cellular histology and concepts of cellular adaptation, such as hypertrophy, hyperplasia, metaplasia, and dysplasia.
Fundamental cell signaling pathways that govern cell growth, survival, and programmed cell death (apoptosis).
The TNM staging system and histopathological grading methods used to assess tumor progression and prognosis.
Advanced molecular mechanisms of metastasis, including epithelial-to-mesenchymal transition (EMT) and organotropism.
Principles of cancer therapeutics, ranging from traditional chemotherapy to targeted therapies and modern immunotherapies like checkpoint inhibitors.
Diagnostic oncology techniques, including immunohistochemistry (IHC), tumor markers, and molecular diagnostics (e.g., next-generation sequencing).
278.3K views5Klikes26:44@medtodayOriginal Release: 2020-11-20

Neoplasia, meaning 'new growth,' refers to abnormal tissue masses arising from a single cell with acquired mutations, resulting in clonal proliferation; tumors are classified as benign (localized, non-invasive, easily removable) or malignant (cancerous, invasive, metastasizing), with malignant tumors characterized by eight fundamental hallmarks including self-sufficiency in growth signals, insensitivity to growth inhibitors, altered metabolism, evasion of apoptosis, limitless replicative potential, sustained angiogenesis, ability to invade and metastasize, and immune escape, which collectively explain cancer development and progression.